US government buys more rapid molecular tests for unknown reasons
What happened
The US government awarded a $3.5 million contract to Cepheid for GeneXpert Infinity Molecular Reagents. These reagents are used in rapid molecular diagnostic tests.
Why it matters
This contract is for routine supplies, not a new technology or a change in policy. It means the government is continuing to use these specific rapid molecular tests. The contract does not specify what these tests are for, or which agency is buying them.
The signal
Watch for future procurement notices from specific agencies that clarify the purpose or scale of these molecular diagnostic purchases.